跳至主要内容
临床试验/NL-OMON21629
NL-OMON21629尚未招募不适用

Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome and a high bleeding risk: optimization of antiplatelet treatment in high-risk elderly

St. Antonius teaching hospital0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) At least 75 years of age.
  • 2) Hospitalization for NSTEMI or unstable angina (UA), according to the following definitions
  • NSTEMI (Non-ST-elevation myocardial infarction) will be defined as detection of a rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with at least one value above the 99th percentile upper reference limit (URL) and with at least one of the following:

排除标准

  • Exclusion criteria
  • 1)Contraindication to P2Y12 inhibitors i.e. clopidogrel, prasugrel or ticagrelor:

研究者

发起方
St. Antonius teaching hospital

相似试验

Ticagrelor of prasugrel versus clopidogrel bij... | 临床试验